Robert Clark
Fortune : 8 375 $ au 31/05/2026
Fortune : 8 375 $ au 31/05/2026
Robert Bruce Clark currently works at Incannex Healthcare, Inc., as Independent Non-Executive Director from 2023 and Novo Nordisk, Inc., as Vice President-US Regulatory Affairs from 2012.
Mr. Clark also formerly worked at Incannex Healthcare Pty Ltd., as Director from 2022 to 2023 and Pfizer Inc., as VP-Worldwide Regulatory Strategy from 1992 to 2021.
Mr. Clark received his graduate degree from New York Medical College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INCANNEX HEALTHCARE INC. 0,02 % | 14/11/2025 | 2 500 ( 0,02 % ) | 8 375 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| INCANNEX HEALTHCARE INC. | Directeur/Membre du Conseil | 01/11/2023 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Conseiller Juridique Général | 01/01/2012 |
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01/01/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Incannex Healthcare, Inc.
Incannex Healthcare, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops cannabinoid and psychedelic compound medicines | Health Technology |
New York Medical College
New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national